Noubar Afeyan
from The David Rubenstein Show Hosted by Bloomberg
Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of The David Rubenstein Show?
This episode is 22 minutes long.
When was this The David Rubenstein Show episode published?
This episode was published on August 19, 2021.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this The David Rubenstein Show episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.